In addition, the serum levels of COL1A1 in lung cancer patients before chemotherapy were significantly higher than in patients after four cycles of chemotherapy (32.67 ± 5.84 ng/ml vs. 19.98 ± 3.95 ng/ml, P < 0.001) (Figure 4B). Here, COL1A1 is linked to lung carcinoma.